Author
Listed:
- François Birault
(Département de Médecine Générale, Faculté de Médecine et de Pharmacie, Université de Poitiers, 86000 Poitiers, France
Maison de Santé Pluriprofessionnelle des Couronneries, 115 r des Couronneries, 86000 Poitiers, France)
- Stéphanie Mignot
(Département de Médecine Générale, Faculté de Médecine et de Pharmacie, Université de Poitiers, 86000 Poitiers, France
Service de Gynécologie Obstétrique, Université, CHU de Poitiers, 86000 Poitiers, France)
- Nicole Caunes
(Département de Médecine Générale, Faculté de Médecine et de Pharmacie, Université de Poitiers, 86000 Poitiers, France
Maison de Santé Pluriprofessionnelle des Couronneries, 115 r des Couronneries, 86000 Poitiers, France)
- Philippe Boutin
(Département de Médecine Générale, Faculté de Médecine et de Pharmacie, Université de Poitiers, 86000 Poitiers, France
Maison de Santé Pluriprofessionnelle des Couronneries, 115 r des Couronneries, 86000 Poitiers, France)
- Emilie Bouquet
(Service de Pharmacologie Clinique et Vigilances, Université, CHU de Poitiers, 86021 Poitiers, France)
- Marie-Christine Pérault-Pochat
(Service de Pharmacologie Clinique et Vigilances, Université, CHU de Poitiers, 86021 Poitiers, France
Service de Pharmacologie Clinique et Vigilances, INSERM U1084-LNEC/INSERM CIC1402, Université, CHU de Poitiers, 86021 Poitiers, France
These two authors contributed equally to this work.)
- Bérangère Thirioux
(Unité de Recherche Clinique Intersectionnelle en Psychiatrie à Vocation Régionale Pierre Deniker, Centre Hospitalier Henri Laborit, 86021 Poitiers, France
These two authors contributed equally to this work.)
Abstract
Background : The French Universal Health Cover (CMU) aims to compensate for inequalities between precarious and non-precarious populations, enabling the former to access to free healthcare. These measures rely on the principle that precarious populations’ health improves if healthcare is free. We designed a study to examine whether CMU fails to compensate for inequalities in reimbursed drugs prescriptions in precarious populations. Material and method : This retrospective pharmaco-epidemiological study compared the Defined Daily Dose relative to different reimbursed drugs prescribed by general practitioners (GPs) to precarious and non-precarious patients in France in 2015. Data were analysed using Mann–Whitney tests. Findings : 6 out of 20 molecules were significantly under-reimbursed in precarious populations. 2 were over-reimbursed. The 12 remaining molecules did not differ between groups. Interpretation : The under-reimbursement of atorvastatin, rosuvastatin, tamsulosine and timolol reflects well-documented epidemiological differences between these populations. In contrast, the equal reimbursement of amoxicillin, pyostacine, ivermectin, salbutamol and tiopropium is likely an effect of lack of compensation for inequalities. Precarious patients are more affected by diseases that these molecules target (e.g., chronic bronchitis, bacterial pneumonia, cutaneous infections). This could also be the case for the equal and under-reimbursement of insulin glargine and metformin (targeting diabetes), respectively, although this has to be considered with caution. In conclusion, the French free healthcare cover does not fail to compensate for all but only for some selective inequalities in access to reimbursed drugs prescriptions. These results are discussed with respect to the interaction of the doctor–patient relationship and the holistic nature of primary care, potentially triggering burnout and empathy decrease and negatively impacting the quality of care in precarious populations.
Suggested Citation
François Birault & Stéphanie Mignot & Nicole Caunes & Philippe Boutin & Emilie Bouquet & Marie-Christine Pérault-Pochat & Bérangère Thirioux, 2020.
"The Characteristics of Care Provided to Population(s) in Precarious Situations in 2015. A Preliminary Study on the Universal Health Cover in France,"
IJERPH, MDPI, vol. 17(9), pages 1-12, May.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:9:p:3305-:d:355895
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:9:p:3305-:d:355895. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.